Search results
The Global Burden of Disease: Generating Evidence, Guiding Policy in Kenya
The Global Burden of Disease: Generating Evidence, Guiding Policy in Kenya explores health progress in Kenya over the past 23 years and examines the challenges the country faces as its population grows and the landscape of its health shifts.
Assessing the complex and evolving relationship between charges and payments in US hospitals: 1996 – 2012
In 2013 the United States spent $2.9 trillion on health care, more than in any previous year. Much of the debate around slowing health care spending growth focuses on the complicated pricing system for services. Our investigation contributes to knowledge of health care spending by assessing the relationship between charges and payments in the inpatient hospital setting. In the US, charges and payments differ because of a complex set of incentives that connect health care providers and funders.
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention strategies. We used data from the Global Burden of Disease (GBD) Study to estimate morbidity and mortality for acute viral hepatitis, and for cirrhosis and liver cancer caused by viral hepatitis, by age, sex, and country from 1990 to 2013.
Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The contribution of modifiable risk factors to the increasing global and regional burden of stroke is unclear, but knowledge about this contribution is crucial for informing stroke prevention strategies. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the population attributable fraction (PAF) of stroke-related disability-adjusted life years (DALYs) associated with potentially modifiable environmental, occupational, behavioral, physiological, and metabolic risk factors in different age and sex groups worldwide and in high-income countries and low-income and middle-income countries, from 1990 to 2013.
Lessons from a decade of suicide surveillance in India: who, why, and how?
This paper investigates trends in suicide rate, the reasons for and means of suicide and the occupation of deceased, to prioritize suicide prevention activities in India and to highlight the limitations to data quality for surveillance.
Global distribution and environmental suitability for chikungunya virus, 1952 to 2015
Chikungunya fever is an acute febrile illness caused by the chikungunya virus (CHIKV), which is transmitted to humans by Aedes mosquitoes. Here we comprehensively assess the global distribution of chikungunya and produce high-resolution maps, using an established modeling framework that combines a comprehensive occurrence database with bespoke environmental correlates, including up-to-date Aedes distribution maps.
The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies
China and India jointly account for 38% of the world population, so understanding the burden attributed to mental, neurological, and substance use disorders within these two countries is essential. As part of the Lancet/Lancet Psychiatry China–India Mental Health Alliance Series, we aim to provide estimates of the burden of mental, neurological, and substance use disorders for China and India from the Global Burden of Disease Study 2013 (GBD 2013).
Survival outcomes for first-line antiretroviral therapy in India’s ART program
Little is known about survival outcomes of HIV patients on first-line antiretroviral therapy (ART) on a large-scale in India, or facility level factors that influence patient survival to guide further improvements in the ART program in India. We examined factors at the facility level in addition to patient factors that influence survival of adult HIV patients on ART in the publicly-funded ART program in a high- and a low-HIV prevalence state.
Global burden of diseases, injuries, and risk factors for young people’s health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Young people’s health has emerged as a neglected yet pressing issue in global development. Changing patterns of young people’s health have the potential to undermine future population health as well as global economic development unless timely and effective strategies are put into place. We report the past, present, and anticipated burden of disease in young people aged 10–24 years from 1990 to 2013 using data on mortality, disability, injuries, and health risk factors.
2015 Dissemination Report
The Gavi Full Country Evaluations (FCE) are prospective studies covering the period 2013-2016 that aim to understand and quantify the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in Bangladesh, Mozambique, Uganda, and Zambia. This third annual dissemination report complements previous reports by providing key findings and recommendations for the 2015 evaluation period in the four evaluation countries.
Bangladesh: Findings from the 2015 Gavi Full Country Evaluations
This report presents findings for Bangladesh from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
Mozambique: Findings from the 2015 Gavi Full Country Evaluations
This report presents findings for Mozambique from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
Uganda: Findings from the 2015 Gavi Full Country Evaluations
This report presents findings for Uganda from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
Zambia: Findings from the 2015 Gavi Full Country Evaluations
This report presents findings for Zambia from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
2015 Cross-Country Evaluation Brief
This brief provides an overview of cross-country findings from the 2015 evaluation year.
Institutional Delivery and Satisfaction among Indigenous and Poor Women in Guatemala, Mexico, and Panama
Indigenous women in Mesoamerica experience disproportionately high maternal mortality rates and are less likely to have institutional deliveries. Identifying correlates of institutional delivery, and satisfaction with institutional deliveries, may help improve facility utilization and health outcomes in this population. We used baseline surveys from the Salud Mesoamérica Initiative to analyze data from 10,895 indigenous and non-indigenous women in Guatemala and Mexico (Chiapas State) and indigenous women in Panama.
Mapping global environmental suitability for Zika virus
Zika virus was discovered in Uganda in 1947 and is transmitted by Aedes mosquitoes, which also act as vectors for dengue and chikungunya viruses throughout much of the tropical world. Possible associations with microcephaly and Guillain-Barré syndrome observed in this outbreak have raised concerns about continued global spread of Zika virus, prompting its declaration as a Public Health Emergency of International Concern by the World Health Organization. We conducted species distribution modelling to map environmental suitability for Zika. We show a large portion of tropical and sub-tropical regions globally have suitable environmental conditions with over 2.17 billion people inhabiting these areas.
The global economic burden of dengue: a systematic analysis
Dengue is a serious global burden. Objective, systematic, comparable measures of dengue burden are needed to track health progress, assess the application and financing of emerging preventive and control strategies, and inform health policy. We estimated the global economic burden of dengue by country and super-region.
Financing Global Health 2015: Development assistance steady on the path to new Global Goals
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries.
Development assistance for health: past trends, associations, and the future of international financial flows for health
Disbursements of development assistance for health (DAH) have risen substantially during the past several decades. More recently, the international community’s attention has turned to other international challenges, introducing uncertainty about the future of disbursements for DAH.
National spending on health by source for 184 countries between 2013 and 2040
In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected.